tiprankstipranks
Advertisement
Advertisement
ResMed price target lowered to $225 from $254 at Baird
PremiumThe FlyResMed price target lowered to $225 from $254 at Baird
19d ago
ResMed price target lowered to $235 from $265 at Stifel
Premium
The Fly
ResMed price target lowered to $235 from $265 at Stifel
19d ago
Analyst Brandon Vazquez Reiterates Buy on ResMed Amid Solid Execution, Margin Expansion, and Attractive Valuation Despite Near-Term Headwinds
Premium
Ratings
Analyst Brandon Vazquez Reiterates Buy on ResMed Amid Solid Execution, Margin Expansion, and Attractive Valuation Despite Near-Term Headwinds
19d ago
ResMed reports Q3 EPS $2.86, consensus $2.72
PremiumThe FlyResMed reports Q3 EPS $2.86, consensus $2.72
20d ago
Notable companies reporting after market close
Premium
The Fly
Notable companies reporting after market close
20d ago
RMD Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
RMD Earnings this Week: How Will it Perform?
22d ago
ResMed price target lowered to $255 from $300 at Evercore ISI
PremiumThe FlyResMed price target lowered to $255 from $300 at Evercore ISI
1M ago
ResMed price target lowered to $340 from $345 at Citi
Premium
The Fly
ResMed price target lowered to $340 from $345 at Citi
1M ago
Resmed: Strong Market Position and Financial Profile Offer Upside Amid Overstated GLP‑1 and Competitive Risks
Premium
Ratings
Resmed: Strong Market Position and Financial Profile Offer Upside Amid Overstated GLP‑1 and Competitive Risks
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100